Extravasation vs. Infiltration, and Vesicant Agents: Understanding the Particulars Involved to Avoid Coding Inaccuracies

It is important for coders and all healthcare professionals to know the difference, and why it matters.

Intravenous therapy (IV) is quite common, administered by healthcare professionals on a very regular basis. As common as it may be, however, it’s linked to an unusually high risk of potential harm to the patient. If a complication occurs, a patient could develop a severe wound, lose function of a limb, or even suffer amputation. Understanding the difference between infiltration and extravasation is essential for healthcare professionals, and just as significant for coders.

What is the difference between infiltration and extravasation?

Whether infiltration or extravasation, both involve an IV solution or medication getting into the tissue surrounding the vein. It is the type of solution or medication that is inadvertently delivered into the surrounding tissue that determines the difference.

Infiltration is the unintentional administration of a non-vesicant medication into surrounding cell tissue. This is a relatively common and generally minor occurrence. Infiltration does not usually cause harm, but the medicine or solution may cause redness, swelling, and discomfort around the site.

Extravasation refers to the unintentional administration of a vesicant medication into the surrounding tissue. These are active chemical substances that can cause blistering, and in extreme cases, necrosis. It is not uncommon for a patient to receive a local injection of a reversal agent if extravasation occurs. If left untreated, the patient may have to have debridement or skin grafting, or he or she could suffer disfigurement, loss of function, and even amputation. 

It is important to note that infiltration and extravasation can exist at the same time. Doctors often use infiltration and extravasation interchangeably. Both are caused when the vein leaks or the IV catheter comes out of the vein; however, extravasation is far more severe. Again, the essential difference between infiltration and extravasation is the type of medicine or fluid that is leaked. Extravasation is much more severe than infiltration due to vesicant agents within an IV solution.

Vesicant Agents

It is important to know if the substance that got into the tissue is a vesicant agent. Vesicants and non-vesicants are the two classes of IV solutions. In both IV solutions and medications, however, vesicant agents are highly reactive chemicals that cause cellular-level changes, resulting in serious or even life-threatening complications.

For coders, when determining if there is a code-able occurrence, the agent that has infiltrated must be taken into account. Further considerations include this question: was it treated, or did it impact the stay?

Coders must identify vesicant agents. Some common examples of vesicant medications and fluids include vancomycin, potassium chloride, calcium gluconate, dopamine, and Dilantin. This type of data may not always be easily accessible. If the coder is in doubt, they must take it one step further – utilize Internet resources, contact a supervisor, or leverage the expertise of a clinical documentation improvement (CDI) colleague. Information can be accessed through the utilization of resources. It is important to leverage all available resources to obtain a true and accurate diagnosis.

Accurate coding and documentation of infiltration and extravasation requires a complete understanding of the difference between the two, and may warrant a more comprehensive examination. For coders, additional efforts may be required to ensure accuracy, in consideration of the many areas that are dependent upon the codes, such as the reputation and quality of the organization, as well as research, and certainly reimbursement.

In keeping up with the expanding complexities of coding and the direct effect codes have on diagnosis assignment, more than ever before, coders must utilize critical thinking skills and all available resources.

Programming Note: Listen to Susan Gatehouse report this story live during Talk Ten Tuesdays today, 10-10:30 a.m. EST.

Facebook
Twitter
LinkedIn

Susan Gatehouse, RHIT, CCS,CPC, AHIMA-Approved ICD-10-CM/PCS Trainer

Susan Gatehouse is the founder and chief executive officer of Axea Solutions. An industry expert in revenue cycle management, Gatehouse established Axea Solutions in 1998, and currently partners with healthcare organizations across the nation, to craft solutions for unique challenges in the dynamic world of healthcare reimbursement and data management.

Related Stories

New Online Drug Lookup Tool Unveiled

New Online Drug Lookup Tool Unveiled

MedLearn Media is launching an online resource believed to be useful for professional coders, charge capture, compliance, and revenue integrity specialists alike. DrugCode Pro is

Read More

Leave a Reply

Please log in to your account to comment on this article.

Featured Webcasts

I050825

Mastering ICD-10-CM Coding for Diabetes and it’s Complications: Avoiding Denials & Ensuring Compliance

Struggling with ICD-10-CM coding for diabetes and complications? This expert-led webcast clarifies complex combination codes, documentation gaps, and sequencing rules to reduce denials and ensure compliance. Dr. Angela Comfort will provide actionable strategies to accurately link diabetes to complications, improve provider documentation, and optimize reimbursement—helping coders, CDI specialists, and HIM leaders minimize audit risks and strengthen revenue integrity. Don’t miss this chance to master diabetes coding with real-world case studies, key takeaways, and live Q&A!

May 8, 2025

Trending News

Featured Webcasts

Navigating the 3-Day & 1-Day Payment Window: Compliance, Billing, and Revenue Protection

Navigating the 3-Day & 1-Day Payment Window: Compliance, Billing, and Revenue Protection

Struggling with CMS’s 3-Day Payment Window? Join compliance expert Michael G. Calahan, PA, MBA, CCO, to master billing restrictions for pre-admission and inter-facility services. Learn how to avoid audit risks, optimize revenue cycle workflows, and ensure compliance across departments. Critical for C-suite leaders, providers, coders, revenue cycle teams, and compliance teams—this webcast delivers actionable strategies to protect reimbursements and meet federal regulations.

May 15, 2025
Audit-Proof Your Wound Care Procedures: Expert Insights on Compliance and Risk Mitigation

Audit-Proof Your Wound Care Procedures: Expert Insights on Compliance and Risk Mitigation

Providers face increasing Medicare audits when using skin substitute grafts, leaving many unprepared for claim denials and financial liabilities. Join veteran healthcare attorney Andrew B. Wachler, Esq., in this essential webcast and master the Medicare audit process, learn best practices for compliant billing and documentation, and mitigate fraud and abuse risks. With actionable insights and a live Q&A session, you’ll gain the tools to defend your practice and ensure compliance in this rapidly evolving landscape.

April 17, 2025
Utilization Review Essentials: What Every Professional Needs to Know About Medicare

Utilization Review Essentials: What Every Professional Needs to Know About Medicare

Dr. Ronald Hirsch dives into the basics of Medicare for clinicians to be successful as utilization review professionals. He’ll break down what Medicare does and doesn’t pay for, what services it provides and how hospitals get paid for providing those services – including both inpatient and outpatient. Learn how claims are prepared and how much patients must pay for their care. By attending our webcast, you will gain a new understanding of these issues and be better equipped to talk to patients, to their medical staff, and to their administrative team.

March 20, 2025

Rethinking Observation Metrics: Standardizing Data for Better Outcomes

Hospitals face growing challenges in measuring observation metrics due to inconsistencies in classification, payer policies, and benchmarking practices. Join Tiffany Ferguson, LMSW, CMAC, ACM, and Anuja Mohla, DO, FACP, MBA, ACPA-C, CHCQM-PHYADV as they provide critical insights into refining observation metrics. This webcast will address key issues affecting observation data integrity and offer strategies for improving consistency in reporting. You will learn how to define meaningful metrics, clarify commonly misinterpreted terms, and apply best practices for benchmarking, and gain actionable strategies to enhance observation data reliability, mitigate financial risk, and drive better decision-making.

February 25, 2025

Trending News

Celebrate Lab Week with MedLearn! Sign up to win one year of our Laboratory All Access Pass! Click here to learn more →

Prepare for the 2025 CMS IPPS Final Rule with ICD10monitor’s IPPSPalooza! Click HERE to learn more

Get 15% OFF on all educational webcasts at ICD10monitor with code JULYFOURTH24 until July 4, 2024—start learning today!

CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 2 with code CYBER24